Steven Lydeamore Chief Executive Officer [email protected] About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercializing ...
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known ...
News-Medical.Net on MSN
Tufts researchers identify new vulnerabilities to combat persistent C. diff infections
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile —commonly known as C. diff —are a serious and persistent problem for patients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results